MDPI and ACS Style
Podlipnik, S.; Boada, A.; López-Estebaranz, J.L.; MartÃn-González, M.M.; Redondo, P.; Martin, B.; Quick, A.P.; Bailey, C.N.; Kurley, S.J.; Cook, R.W.;
et al. Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I–II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study. Cancers 2022, 14, 1060.
https://doi.org/10.3390/cancers14041060
AMA Style
Podlipnik S, Boada A, López-Estebaranz JL, MartÃn-González MM, Redondo P, Martin B, Quick AP, Bailey CN, Kurley SJ, Cook RW,
et al. Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I–II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study. Cancers. 2022; 14(4):1060.
https://doi.org/10.3390/cancers14041060
Chicago/Turabian Style
Podlipnik, Sebastian, Aram Boada, Jose L. López-Estebaranz, Manuel M. MartÃn-González, Pedro Redondo, Brian Martin, Ann P. Quick, Christine N. Bailey, Sarah J. Kurley, Robert W. Cook,
and et al. 2022. "Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I–II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study" Cancers 14, no. 4: 1060.
https://doi.org/10.3390/cancers14041060